Physician profile
Anuj Patel
NPI 1497042105
$1,406.20
in general payments reported to CMS, 2019-2025
19 companies · $19.92 in 2025
The $19.92 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $537 · 2020: $97.61 · 2021: $384 · 2023: $195 · 2024: $173 · 2025: $19.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $387.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $266.81 | 2021-2024 | Synchromedii |
| Janssen Pharmaceuticals, INC | $187.93 | 2020-2021 | |
| Boston Scientific Corporation | $185.72 | 2019 | |
| Aurinia Pharma U.S., INC. | $166.72 | 2023 | Lupkynis |
| Merck Sharp & Dohme LLC | $97.58 | 2021-2025 | Bridion |
| Collegium Pharmaceutical, INC. | $72.35 | 2019-2021 | |
| Daiichi Sankyo INC. | $67.32 | 2019 | |
| Sentynl Therapeutics, INC. | $56.78 | 2019-2020 | |
| Medtronic USA, INC. | $51.31 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.37 | 2019-2020 | |
| Cumberland Pharmaceuticals, INC. | $44.23 | 2019-2023 | Caldolor |
| Pfizer INC. | $34.56 | 2019 | |
| Lilly USA, LLC | $24.69 | 2021 | |
| West Therapeutics Development, LLC | $21.18 | 2019 | |
| Biodelivery Sciences International, INC. | $19.99 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $17.37 | 2019 | |
| Shionogi INC | $16.47 | 2019 | |
| Assertio Therapeutics, INC. | $15.33 | 2020 | |
| Glaxosmithkline, LLC. | $14.49 | 2023 | Benlysta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anuj Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.